Organon (OGN) Change in Inventory (2020 - 2026)
Organon (OGN) recorded quarterly Change in Inventory of $9.0 million in Q1 2026, up 111.11% quarter-over-quarter from -$81.0 million in Q4 2025, and up 400.0% on a YoY basis from $1.8 million in Q1 2025.
Organon (OGN) Change in Inventory (2020 - 2026) Analysis & Trends
Organon's Change in Inventory history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 400.0% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $25.0 million (down 82.99% YoY), while the FY2025 annual figure was $13.0 million, down 90.08% from the prior year.
- Change in Inventory was $9.0 million for Q1 2026 at Organon, up from -$81.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $95.0 million in Q2 2022 to a low of -$81.0 million in Q4 2025.
- Historically, Change in Inventory has averaged $35.5 million across 5 years, with a median of $38.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 361.29% in 2025, then soared 400.0% in 2026.
- A 5-year view of Change in Inventory shows it stood at $86.0 million in 2022, then rose by 8.14% to $93.0 million in 2023, then tumbled by 66.67% to $31.0 million in 2024, then slumped by 361.29% to -$81.0 million in 2025, then surged by 111.11% to $9.0 million in 2026.
- The last three Change in Inventory figures came in at $9.0 million (Q1 2026), -$81.0 million (Q4 2025), and $63.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn | 431.00 Mn |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn | 184.00 Mn |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn | - |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn | -14.00 Mn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Sep 30, 2025 | 63.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 58.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Mar 31, 2024 | -19.00 Mn |
| Dec 31, 2023 | 93.00 Mn |
| Dec 31, 2023 | 93.00 Mn |